New Partnership Announcement: Clario and Trial Data bring new decentralized clinical trial solutions to the Chinese market
- Clario partners with Trial Data, a leading DCT provider, to advance patient-centric decentralized clinical trial methodologies and technologies in China.
- This collaboration combines vast DCT experience and eCOA solutions, along with deep clinical trial operations experience in China, resulting in increased capabilities and flexibility in clinical trial strategies for sponsors supporting clinical trials in China.
- Milestone partnership expands Clario’s presence in China to enhance the clinical trial landscape with innovative technology solutions.
PHILADELPHIA, PA – October 19, 2023 – Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, today announced a strategic partnership with Trial Data, a leading decentralized clinical trial (DCT) service provider, to bring innovative decentralized clinical trials solutions to the Chinese market and advance patient-centric clinical trials in China.
Decentralized clinical trial offerings are increasingly pivotal in modern clinical trial design. This collaboration combines Clario’s 25 years of DCT experience and innovative electronic Clinical Outcome Assessments (eCOA) solutions with Trial Data’s integrated DCT platform and its extensive experience in clinical trial operations in China. This partnership is set to provide sponsors supporting clinical trials in China with unparalleled access to the world’s leading solutions and, ultimately, more choice and flexibility in study protocols and for trial participants.
“Our partnership with Trial Data marks a new milestone for Clario’s expansion in China,” said, Terry Burke, Executive Vice President, electronic Clinical Outcome Assessment (eCOA), Clario. “By joining forces, we aim to combine our unique capabilities and resources to help Life Sciences companies embrace innovative technology to transform patients’ lives.”
To learn more about Clario’s eCOA Clinical Trial Solutions, please go to Clario.com.
Clario is a leading healthcare research and technology company that generates the richest clinical evidence in the industry for our pharmaceutical, biotech and medical device partners. Across decentralized, hybrid and site-based trials, our deep scientific expertise, global scale and the broadest endpoint technology platform in the industry allows our partners to transform lives. Clario has the only technology platform that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Clario’s global team of science, technology and operational experts have helped deliver more than 27,000 trials and contributed to over 500 FDA and EMEA new drug approvals involving more than seven million participants in over 100 countries. Our innovation has been transforming clinical trials for 50 years.
Clario Media Contact
Snr. Director, Content and Communications
+44 7307 533 162